We treated 108 patients with a pertrochanteric femoral fracture using either the dynamic hip screw or the proximal femoral nail in this prospective, randomised series. We compared walking ability before fracture, intra-operative variables and return to their residence. Patients treated with the proximal femoral nail (n = 42) had regained their pre-operative walking ability significantly (p = 0.04) more often by the four-month review than those treated with the dynamic hip screw (n = 41). Peri-operative or immediate post-operative measures of outcome did not differ between the groups, with the exception of operation time. The dynamic hip screw allowed a significantly greater compression of the fracture during the four-month follow-up, but consolidation of the fracture was comparable between the two groups. Two major losses of reduction were observed in each group, resulting in a total of four revision operations.
The incidence of pertrochanteric femoral fractures has increased significantly during recent decades, and this tendency will probably continue in the near future due to the rising age of the population. 1, 2 The goal of the treatment of these fractures is stable fixation, which allows early mobilisation of the patient. In order to achieve this objective, several intramedullary nails have been developed. These nails may challenge the previous role of the compression screw as the standard method of fixation. The advantages and disadvantages of the original design of the Gamma nail have been well established in previous studies, usually by comparing the results with the dynamic hip screw (DHS). 3 Less data are available about an alternative, the proximal femoral nail (PFN), since most previous studies are retrospective and lack a control group. 4, 5 Moreover, the main focus in previous controlled studies has been aimed at technique and clinical results, or on the rehabilitation of the patients in general. 6 We do not know if there is a difference in the post-operative recovery of walking, or where the patient lives, depending upon which implant is used.
The purpose of this study was to assess the patients' recovery after operative treatment of a pertrochanteric femoral fracture with either DHS or PFN, in a randomised, prospective series of 108 patients.
Patients and Methods
Between October 1999 and February 2001, we randomised 108 patients with low-energy extracapsular pertrochanteric femoral fractures (AO category 31-A) 7 to be treated with the dynamic hip screw (Synthes-Stratec, Oberdorf, Switzerland) or the proximal femoral nail (Synthes-Stratec). The ethics committee of our hospital approved the study plan and informed consent was obtained from all patients before the operation. Everyone admitted to our hospital with a pertrochanteric fracture during the study period was considered eligible for the study, but those with a pathological fracture, multiple injuries, and who were unable to give informed consent or refused to participate, were excluded.
Plain radiographs were obtained on admission, and all fractures were categorised according to the AO/ASIF classification. 7 The mode of treatment was determined by strict randomisation, using sealed envelopes. The domestic circumstances of each patient was classified into three categories: living in one's own home, in a nursing home, or an institution such as a long-stay hospital ward. Walking ability was classified into three categories: able to walk independently without aids, walking independently with the help of aids (crutches or frame) and walking only when assisted by another person. The use of a walking stick was not considered to be an extra aid, and patients using one were categorised as independent walkers.
The operation was usually performed within two days of admission, in most cases by a senior orthopaedic resident. All fractures were reduced by closed means. Standard operative techniques, which are recommended by the manufacturer and have been described in detail in instruction manuals or earlier studies 7, 8 were used. All patients received a prophylactic dose of an intravenous antibiotic, and were also treated with low-molecular-weight heparin during their stay in hospital. Intra-operative factors were considered as secondary outcome measures.
Plain anteroposterior (AP) and lateral radiographs were obtained on the first post-operative day, and analysed for reduction of the fracture and position of the implant. Reduction was considered good if the cortical congruence at the calcar region was restored, and if the displacement between the fragments did not exceed 2 mm in any projection. The ideal position for the screw in the femoral neck for both the DHS and the PFN was defined as being central on the lateral radiograph and central or inferior on the AP radiograph 9 ( Figs 1 and 2 ). Walking weight-bearing within the limits of pain was usually begun on the first or second post-operative day. The rehabilitation protocol was uniform, regardless of the method of fixation. The patients were discharged when mobile and primary complications had been excluded.
Follow-up reviews were undertaken at six weeks and four months post-operatively. Plain AP and lateral radiographs were obtained at both visits. All changes in the position of the fracture and implant, when compared with the post-operative radiographs, were recorded and considered as secondary measures of outcome. Where the patient lived and their ability to walk were recorded as in the pre-operative phase. A return to the pre-operative level was considered as a primary measure of outcome.
The statistical analysis was performed using SPSS for Windows (SPSS Inc, Chicago, Illinois). Odds ratios and means were compared between the groups, with 95% confidence intervals (CI) excluding the value of one and zero respectively, being considered as statistically significant differences. P values were calculated with independent samples t-test and with cross-tabulation using Fisher's exact test; values of p < 0.05 were considered as significant. Figure 2c -Healing of the fracture occurred uneventfully, but some displacement of the tip of the greater trochanter occurred. She had returned to living at home and was able to walk independently at four months. 
Results
The two treatment groups were comparable in features before the fracture occurred (Table I ). The median operation time was 50 minutes (20 to 200), with the operation of PFN being generally more time consuming (Table II) . The mean blood loss was 339 ml (50 to 2800), and the mean number of transfused red blood cell units (400 cc/unit) during the hospital stay was 2.6 (0 to 11). Spinal anaesthesia was used in 103 (95.4%) of the 108 operations. Reduction of the fracture was considered good in 68 (63.0%), and the position of the implant as ideal in 85 (78.7%) of the postoperative radiographs. The patients were discharged at a mean of six days (1 to 15) post-operatively usually to a rehabilitation hospital (92 patients, 85.2%). Two patients died in the immediate post-operative period from cardiovascular causes.
Five complications were observed during the follow-up of four months. There were two cases of redisplacement of the fracture in both groups (Table III ). All four patients had revision operations. One case of heterotopic ossification, corresponding to Brooker class 4, 10 was observed where a PFN had been used. However, this finding did not affect the patient's recovery and walking ability was regained at four months. No superficial or deep wound infections, or deep vein thromboses, were observed.
At four months, 87 (80.6%) of the initial 108 patients were eligible for an analysis of outcome. Of the 21 not eligible for analysis, two died in the immediate post-operative period and another four died before completion of the follow-up. Fifteen patients did not attend final review because they were too ill. The four patients who had revisions were excluded, and a final analysis of the outcome was thus performed for 83 patients (Table IV) . The mean compression of the fracture, indicated as shortening of the femoral neck, was 3.6 mm (0 to 30), with a significant difference between the groups (Table V) . The mean shortening of the shaft of the femur was 3.5 mm (0 to 25), when measured from AP radiographs. At four months follow-up, 46 (55.4%) patients lived in their own home, 16 (19.3%) in a nursing 
Discussion
The use of a DHS has been supported by biomechanical properties 11 which are assumed to improve the healing of fractures. At present, the longest follow-up studies available are those of the Gamma nail (Stryker Howmedica, Freiburg, Germany). Although acceptable rates of fracture healing have been reported, 12 several studies have shown an increased risk of both operative and post-operative complications, mainly femoral fractures, associated with the original design of this nail. 13, 14 Recent meta-analyses have suggested that the DHS should be favoured for the treatment of pertrochanteric fractures. 15, 16 The PFN has been developed as an alternative to the Gamma nail, and it seems to be associated with a lower incidence of complications. 17 So far, the published reports of the PFN are promising, although much of the data are available only from retrospective studies which do not include a control group.
One of the few controlled studies of the PFN is a randomised series of 168 patients, in which several intra-operative, radiographic and clinical measures of outcome were compared between the DHS and PFN after a minimum follow-up of one year. 18 In line with our results, 87 (51.8%) of the patients lived at home, but the authors did not report the number of patients who were able to walk independently. Although the mean pre-and post-operative scores of function and mobility did not differ significantly between the treatment groups, there was an increase by a factor of 1.5 in the score for social function during follow-up in the PFN group compared with the DHS group. Moreover, the score for mobility was reduced more in the patients treated with PFN. The statistical significance of these observations, as well as the power of the study, were not reported. 18 The results from that study suggest that the use of a DHS may allow more patients to return to their previous level of activity. 18 In contrast, patients in our study who were treated with a PFN regained their pre-operative walking ability at four months significantly more often than those treated with a DHS. Although the statistical power of this finding was not very strong, it suggests that the use of a PFN may favour better restoration of function in the elderly population, compared with the use of a DHS. One explanation might be the significantly greater impaction of the fracture in the DHS group, with shortening of the femoral neck. It is possible that substantial compression of the fracture may alter the biomechanics of the hip and prevent the restoration of the ability to walk. Post-operative mobilisation was equally successful for both groups, which suggests that the differences between the implants are insignificant in the primary phase. Moreover, the lack of compression in the PFN group did not seem to interfere with the healing of the fracture.
Approximately 50% of patients returned to where they had lived before their operation, without any correlation to the implant which was used. This finding agrees with the results from retrospective studies of Banan et al, 19 Al-Yassari et al 20 and Simmermacher et al 8 who also observed restoration of pre-operative mobility in approximately 40% to 50% of the patients treated with a PFN. Similarly, the use of a DHS and a Gamma nail seems to generate comparable results. 14, 21 It therefore seems reasonable to expect approximately half the patients with a pertrochanteric fracture to resume their pre-operative domestic status at the time of healing of the fracture, regardless of the method of treatment used. However, even better results have been reported. 4 In respect of secondary measures of outcome, only operation time differed significantly between the treatment groups. Re-displacement of the fracture occurred in an equal percentage of patients in both groups. Fracture of the femoral diaphysis at the tip of the nail is a known complication associated with the use of intramedullary nails in the treatment of proximal femoral fractures. We did not observe any in our series but our follow-up was short.
A common problem in previous studies, as in ours, is the high number of those who were withdrawn, even after a short follow-up. This is partially explained by the age of the patients. In our series, the 19 patients who did not attend their final review had either died during the first four months after operation at another hospital, or were too ill to attend. Although the high drop-out rate may bias the outcome when the overall recovery from the operation is assessed, it does not change the interpretation of the results when the two methods are compared, if the rate is equal between the two groups.
Our results suggest that the use of a PFN in the treatment of trochanteric femoral fractures may have a positive effect on the speed of restoration of walking, when compared with patients treated with a DHS. The relatively wellrestored anatomy of the hip may explain this. As our results partially conflict with previous reports, more randomised studies with larger numbers of patients are needed in order to decide which is the ideal implant for the treatment of these fractures.
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